NIH-funded research NIH-funded research

Using osteoclast-derived microvesicles to speed bone healing

Official title: Osteoclastic Regulation of Local Bone Formation

Funded at VA Loma Linda Healthcare System · NIH-11264887 · Data updated 2026-11-12

This project aims to use tiny particles released by bone-resorbing cells to speed and strengthen healing in people with broken bones.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Loma Linda Healthcare System
NIH-funded
Lab location1 site (Loma Linda, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2027
Funding year2026
NIH project number5I01BX006038-03
Project IDNIH-11264887 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be people with recent fractures—especially those at higher risk for delayed healing—who might be eligible for a localized regenerative treatment at the fracture site.

Less likely to help

People with fractures caused by active bone infection, severe poor blood flow, or certain systemic conditions that block healing may not benefit from this local microvesicle therapy.

What this research studies

If you have a broken bone, this project looks at tiny membrane-bound particles (microvesicles) released by osteoclasts — the cells that break down bone — to help form new bone in the fracture callus. Researchers will deliver these microvesicles locally into fractures in lab models to see whether they speed callus formation and remodeling. The work builds on early laboratory findings showing these vesicles can stimulate bone- and cartilage-forming cells and uses mouse fracture models to study how the process works. The long-term goal is to move toward treatments that could be applied near a break to shorten recovery and reduce nonunion.

Why it matters

Potential benefit: If successful, this approach could speed fracture healing, lower the risk of delayed union or nonunion, and shorten recovery times.

How similar studies have gone: Preclinical animal and laboratory studies indicate osteoclast-derived microvesicles have pro-bone and pro-cartilage effects, but human testing of this approach is novel and unproven.

Where this research is happening

  • VA Loma Linda Healthcare System
    Loma Linda, United States
    Active

Researchers

  • Principal investigator: Lau, Kin-Hing William — VA Loma Linda Healthcare System
  • Study coordinator: Lau, Kin-Hing William

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.